• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Viemed Healthcare Inc. (Amendment)

    2/15/24 9:27:32 AM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care
    Get the next $VMD alert in real time by email
    SC 13G/A 1 sc13g_achoyt-2152024.htm SC 13G/A Document

    SECURITIES AND EXCHANGE COMMISSION
    Washington, DC 20549

    SCHEDULE 13G
    Under the Securities Exchange Act of 1934

    (Amendment No. 4)1

    Viemed Healthcare, Inc.
    (Name of Issuer)

    Common Shares, No Par Value
    (Title of Class of Securities)

    92663R105
    (CUSIP Number)

    December 31, 2023
    (Date of Event which Requires Filing of this Statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    ☐ Rule 13d-1(b)
    ☐ Rule 13d-1(c)
    ☒ Rule 13d-1(d)













    1The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
    1


    1.
    NAMES OF REPORTING PERSONS    

    Casey Hoyt
    2.
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
    (a)☐
    (b)☐
    3.SEC USE ONLY
    4.
    CITIZENSHIP OR PLACE OF ORGANIZATION    United States
    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH
    5.SOLE VOTING POWER1,105,246
    6.SHARED VOTING POWER2,010,943
    7.SOLE DISPOSITIVE POWER1,105,246
    8.SHARED DISPOSITIVE POWER2,010,943
    9.
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     3,116,1892 shares of Common Stock
    10.CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
    CERTAIN SHARES (SEE INSTRUCTIONS)
        ☐
    11.
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)    8.0%2
    12.
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)    IN

    2Assumes 38,756,636 Common Shares of the Company outstanding as of February 15, 2024 based on information provided by the Issuer.
    2




    1.
    NAMES OF REPORTING PERSONS    

    Elizabeth Rose Homes LLC
    2.
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
    (a)☐
    (b)☐
    3.SEC USE ONLY
    4.
    CITIZENSHIP OR PLACE OF ORGANIZATION    Louisiana
    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH
    5.SOLE VOTING POWER0
    6.SHARED VOTING POWER2,010,943
    7.SOLE DISPOSITIVE POWER0
    8.SHARED DISPOSITIVE POWER2,010,943
    9.
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    2,010,943 shares of Common Stock
    10.CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
    CERTAIN SHARES (SEE INSTRUCTIONS)
        ☐
    11.
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)    5.2%3
    12.
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)    OO (Limited Liability Company)





    3 Assumes 38,756,636 Common Shares of the Company outstanding as of February 15, 2024 based on information provided by the Issuer.
    3


    Item 1.        

    (a)Name of Issuer - Viemed Healthcare, Inc., an entity incorporated pursuant to the Business Corporations Act (British Columbia) (the “Issuer”).

    (b)Address of Issuer’s Principal Executive Offices - 625 E. Kaliste Saloom Rd, Lafayette, Louisiana 70508.

    Item 2.        

    (a)Name of Person Filing - - this Statement is being filed on behalf of each of the following persons (collectively, the “Reporting Persons”):

    •Casey Hoyt, a natural person (“Hoyt”).
    •Elizabeth Rose Homes LLC, a Louisiana limited liability company (“ERH LLC”).

    (b)Address of Principal Business Office or, if none, Residence:

    •Hoyt - 625 E. Kaliste Saloom Rd, Lafayette, Louisiana 70508.
    •ERH LLC – 625 E. Kaliste Saloom Rd, Lafayette, Louisiana 70508.

    (c)Citizenship:
    •Hoyt - United States of America.
    •ERH LLC – a Louisiana limited liability company.

    (d)Title of Class of Securities - Common shares, no par value, (the “Common Shares”) of the Issuer.

    (e)CUSIP Number - 92663R105.

    Item 3.        If this Statement is filed pursuant to Rules 13d-1(b) or 13d-2(b) or (c).

    Not applicable.
    Item 4.         Ownership.

    The percentages used herein are calculated based on 38,756,636 Common Shares issued and outstanding as of February 15, 2024, based on information provided by the Issuer.

    (a)Amount beneficially owned
    ▪Hoyt beneficially owns 3,116,189 Common Shares, which amount includes 2,010,943 shares held by ERH LLC and 918,037 shares issuable upon the exercise of options that are vested or will vest within 60 days.
    ▪ERH LLC beneficially owns 2,010,943 Common Shares, which shares were transferred by Hoyt to ERC LLC on August 14, 2023 for estate planning purposes. Hoyt owns 50% of the ownership units in ERC LLC and serves as a general manager of ERC LLC.

    4


    (b)Percent of class
    •Hoyt – 8.0%
    •ERH LLC – 5.2%.

    (c)Number of shares as to which the person has:

    i.Sole power to vote or to direct the vote:
    •Hoyt - 1,105,246
    •ERH LLC - 0

    ii.Shared power to vote or direct the vote:
    •Hoyt - 2,010,943
    •ERH LLC - 2,010,943

    iii.Sole power to dispose or to direct the disposition of:
    •Hoyt - 1,105,246
    •ERH LLC - 0

    iv.Shared power to dispose or to direct the disposition of:
    •Hoyt - 2,010,943
    •ERH LLC - 2,010,943

    On February 15, 2024, the Reporting Persons entered into a Joint Filing Agreement relating to the filing of this Schedule 13G, a copy of which is annexed hereto as Exhibit 99.1.


    Item 5.         Ownership of Five Percent or Less of a Class.

    Not applicable.

    Item 6.        Ownership of More than Five Percent on Behalf of Another Person.

    Not applicable.

    Item 7.        Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

    Not applicable.

    Item 8.        Identification and Classification of the Members of the Group.

    Not applicable.

    Item 9.        Notice of Dissolution of Group.

    Not applicable.

    Item 10.    Certifications.

    5


    Not applicable.


    SIGNATURE

        After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date:    February 15, 2024



        /s/ Casey Hoyt    
    Casey Hoyt



    Elizabeth Rose Homes LLC

    /s/ Casey Hoyt
    Casey Hoyt, General Manager

    6


    Exhibit 99.1

    JOINT FILING AGREEMENT

    The undersigned hereby agree that the statement on Schedule 13G with respect to the shares of common stock of Viemed Healthcare, Inc. dated as of February 15, 2024 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.


    /s/ Casey Hoyt
    Casey Hoyt

    Elizabeth Rose Homes LLC

    /s/ Casey Hoyt
    Casey Hoyt, General Manager

    7
    Get the next $VMD alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $VMD

    DatePrice TargetRatingAnalyst
    11/3/2021$13.00 → $9.00Outperform
    RBC Capital
    More analyst ratings

    $VMD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Heltz Sabrina bought $19,977 worth of shares (2,820 units at $7.08), increasing direct ownership by 7% to 41,040 units (SEC Form 4)

    4 - VIEMED HEALTHCARE, INC. (0001729149) (Issuer)

    5/14/24 5:25:11 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    $VMD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Viemed Healthcare Announces Share Repurchase Program

    LAFAYETTE, La., June 09, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader of in-home, technology-enabled post-acute respiratory care, today announced that its Board of Directors has authorized a share repurchase program, effective through June 2026. Under the share repurchase program, Viemed may purchase up to 1,976,441 common shares of the Company ("the Common Shares") from time to time in accordance with applicable securities laws, representing approximately 5% of the total issued and outstanding Common Shares as of March 31, 2025. The Company intends to repurchase Common Shares through open market purchases, block purchases o

    6/9/25 8:00:00 AM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    Viemed Healthcare to Present and Host 1x1 Investor Meetings at the 15th Annual East Coast Ideas Investor Conference on June 11th in New York

    LAFAYETTE, La., June 03, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, today announced it will present at the East Coast IDEAS Investor Conference on Wednesday June 11, 2025 at The Westin Times Square in New York, NY. Viemed's presentation is scheduled to begin at 11:30am ET. The presentation is webcast and can be accessed through the conference host's main website: https://www.threepartadvisors.com/east-coast and in the investor relations section of the Company's website: http://viemed.com/investors. ABOUT VIEMED HEALTHCARE, INC. Viemed is an

    6/3/25 8:00:00 AM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    Viemed Healthcare Announces First Quarter 2025 Financial Results

    LAFAYETTE, La., May 07, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three months ended March 31, 2025, and updated guidance for the full year ending December 31, 2025. Operational highlights (all dollar amounts are USD): Net revenues for the quarter ended March 31, 2025 were $59.1 million, representing an increase of $8.5 million, or 17%, over net revenues reported for the comparable quarter ended March 31, 2024. Net income attributable to Viemed for t

    5/7/25 4:45:00 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    $VMD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    RBC Capital reiterated coverage on Viemed Healthcare with a new price target

    RBC Capital reiterated coverage of Viemed Healthcare with a rating of Outperform and set a new price target of $9.00 from $13.00 previously

    11/3/21 9:01:34 AM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    Royal Bank of Canada initiated coverage on Viemed Healthcare with a new price target

    Royal Bank of Canada initiated coverage of Viemed Healthcare with a rating of Outperform and set a new price target of $13.00

    3/11/21 8:08:09 AM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    RBC Capital initiated coverage on Viemed Healthcare with a new price target

    RBC Capital initiated coverage of Viemed Healthcare with a rating of Outperform and set a new price target of $13.00

    3/5/21 8:11:16 AM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    $VMD
    SEC Filings

    View All

    SEC Form S-8 filed by Viemed Healthcare Inc.

    S-8 - VIEMED HEALTHCARE, INC. (0001729149) (Filer)

    8/12/25 4:39:52 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 10-Q filed by Viemed Healthcare Inc.

    10-Q - VIEMED HEALTHCARE, INC. (0001729149) (Filer)

    8/6/25 5:06:51 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    Viemed Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - VIEMED HEALTHCARE, INC. (0001729149) (Filer)

    8/6/25 5:04:31 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    $VMD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Kaushal Nitin converted options into 15,732 shares, increasing direct ownership by 12% to 142,575 units (SEC Form 4)

    4 - VIEMED HEALTHCARE, INC. (0001729149) (Issuer)

    8/20/25 6:22:41 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    Director Smokoff Timothy converted options into 15,732 shares, increasing direct ownership by 20% to 95,518 units (SEC Form 4)

    4 - VIEMED HEALTHCARE, INC. (0001729149) (Issuer)

    8/20/25 6:22:15 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    Director Dobbs Randy E. converted options into 17,784 shares, increasing direct ownership by 17% to 125,490 units (SEC Form 4)

    4 - VIEMED HEALTHCARE, INC. (0001729149) (Issuer)

    8/20/25 6:20:37 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    $VMD
    Leadership Updates

    Live Leadership Updates

    View All

    Viemed Executes Diversification Strategy With $26 Million Acquisition of Home Equipment Provider in Illinois

    LAFAYETTE, La., May 06, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, announced that it has entered into a definitive agreement to acquire Illinois-based Lehan's Medical Equipment ("Lehan"), a healthcare company offering home medical equipment with specialties in respiratory care and women's health. "Operating for nearly 80 years, Lehan has established a well-deserved reputation for its expertise in home medical equipment with a particular emphasis on women's health and a deep commitment to community engagement," said Viemed Chief

    5/6/25 8:30:00 AM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    Viemed Announces Acquisition of Majority Interest in HomeMed, Forging Partnership With East Alabama Health

    LAFAYETTE, La., April 02, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced the finalization of its strategic partnership with East Alabama Health ("EAH"), providing Viemed with the controlling interest of East Alabama HomeMed, LLC ("HomeMed"). HomeMed provides home medical equipment services to patients within the EAH network as well as those in the surrounding areas of Eastern Alabama. "We are thrilled to join forces with the exceptional team at East Alabama Health to deliver best-in-class home medical services to their patients and expand Home

    4/2/24 9:00:00 AM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    Viemed Healthcare Announces Voting Results From Its Annual General Meeting of Shareholders

    LAFAYETTE, La., June 13, 2023 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD, TSX:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, today announced the voting results from its annual general meeting of shareholders held on June 13, 2023 (the "Meeting") in Lafayette, Louisiana. The total number of shares represented in person or by proxy at the Meeting was 27,309,147, representing 71.33% of the total issued and outstanding shares in the capital of the Company. Election of Directors The eight candidates nominated for election to the Company's Board of Directors (the "Board") and listed in the Company's m

    6/13/23 5:00:00 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    $VMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by Viemed Healthcare Inc. (Amendment)

    SC 13D/A - VIEMED HEALTHCARE, INC. (0001729149) (Subject)

    2/15/24 9:27:58 AM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13G/A filed by Viemed Healthcare Inc. (Amendment)

    SC 13G/A - VIEMED HEALTHCARE, INC. (0001729149) (Subject)

    2/15/24 9:27:32 AM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13G filed by Viemed Healthcare Inc.

    SC 13G - VIEMED HEALTHCARE, INC. (0001729149) (Subject)

    2/14/24 4:51:42 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    $VMD
    Financials

    Live finance-specific insights

    View All

    Viemed Healthcare Announces First Quarter 2025 Financial Results

    LAFAYETTE, La., May 07, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three months ended March 31, 2025, and updated guidance for the full year ending December 31, 2025. Operational highlights (all dollar amounts are USD): Net revenues for the quarter ended March 31, 2025 were $59.1 million, representing an increase of $8.5 million, or 17%, over net revenues reported for the comparable quarter ended March 31, 2024. Net income attributable to Viemed for t

    5/7/25 4:45:00 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    Viemed Healthcare Announces First Quarter 2025 Earnings Conference Call Details

    LAFAYETTE, La., April 22, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, today announced that it will host its First Quarter 2025 Earnings Conference Call on Thursday, May 8, 2025, at 11:00 a.m. EDT. Interested parties may participate in the call by dialing: (866) 682-6100 (US Toll-Free) +1 (862) 298-0702 (International) Live Audio Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=0dOJVhdb Following the live call, a replay will be available in the Investor Relations section of the Company's website at www.viemed.com. ABOUT VIE

    4/22/25 4:30:00 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    Viemed Healthcare Announces Record 2024 Financial Results

    LAFAYETTE, La., March 10, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three months and year ended December 31, 2024, and issued its guidance for the full year ending December 31, 2025. Fourth Quarter and Full Year Operational Highlights (all dollar amounts are USD): Net revenues for the quarter ended December 31, 2024 reached a new Company record of $60.7 million representing an increase of $10.0 million, or 20%, over net revenues reported for the comparable quarter ended Decembe

    3/10/25 5:00:00 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care